Table 1.
GPCR Ligand | Involved GPCR | Pathway | Effect on TRPV1 | Reference |
---|---|---|---|---|
Bradykinin | B | G-DAG-PKC | increased current | [2,41] |
Serotonin | 5-HT | G-DAG-PKC | increased current | [42,43,44] |
5-HT | G-AC-PKA | increased current | [43] | |
5-HT | G-AC-PKA | increased current | [42] | |
UTP | P2Y | G-DAG-PKC | increased current | [45,46,47] |
BAM 8-22 | MRGPRX1 | G-DAG-PKC-PIP | increased current | [48] |
Proteases | PAR2 | G-PKC | increased current | [49,50] |
PAR1 | G-PKC | increased current | [51] | |
PAR4 | G-PKC | increased current | [51] | |
PGE | EP | G-PKC | increased current | [52] |
EP | G-PKA | increased current | [52,53,54] | |
PGI | IP | G-PKC | increased current | [52] |
IP | G-PKA | increased current | [52] | |
Endothelin-1 | ET | G -PKC | increased current | [55,56] |
Substance P | NK | G -PKC | increased current | [57] |
NK | G-PKC | increased current | [58] | |
H | TDAG8 (GPR65) | G-PKA | increased current | [59] |
Morphine | MOP | G-reduced AC | decreased current | [60,61] |
Endocannabinoids | CB | G-reduced AC | decreased current | [62] |
CB | G-reduced AC | decreased current | [63] |
AC, adenylyl cylcase; DAG, diacylglycerol; PKA, proteinkinase A; PKC, protein kinase C; BAM 8–22, bovine adrenal medulla peptide 8–22.